These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 3575009)

  • 1. Tuberculosis in Bacillus Calmette-Guérin-immunized and unimmunized children in Sweden: a ten-year evaluation following the cessation of general Bacillus Calmette-Guérin immunization of the newborn in 1975.
    Romanus V
    Pediatr Infect Dis J; 1987 Mar; 6(3):272-80. PubMed ID: 3575009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Childhood tuberculosis in Sweden. An epidemiological study made six years after the cessation of general BCG vaccination of the newborn.
    Romanus V
    Tubercle; 1983 Jun; 64(2):101-10. PubMed ID: 6604357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacillus Calmette-Guérin revaccination questionable with low tuberculosis incidence.
    Tala-Heikkilä MM; Tuominen JE; Tala EO
    Am J Respir Crit Care Med; 1998 Apr; 157(4 Pt 1):1324-7. PubMed ID: 9563757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of tuberculosis infection and tuberculous meningitis after discontinuation of Bacillus Calmette-Guerin in Beijing.
    Zhang LX; Tu DH; He GX; Ma ZQ; Nagelkerke NJ; Borgdorff MW; Enarson DA; Broekmans JF
    Am J Respir Crit Care Med; 2000 Oct; 162(4 Pt 1):1314-7. PubMed ID: 11029337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective BCG vaccination in a country with low incidence of tuberculosis.
    Romanus V
    Euro Surveill; 2006; 11(3):14-7. PubMed ID: 16567880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of changing BCG coverage on tuberculosis incidence in Swedish-born children between 1969 and 1989.
    Romanus V; Svensson A; Hallander HO
    Tuber Lung Dis; 1992 Jun; 73(3):150-61. PubMed ID: 1421348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and immunogenicity of Bacillus Calmette-Guerin vaccine in children born to HIV-1 infected women.
    Thaithumyanon P; Thisyakorn U; Punnahitananda S; Praisuwanna P; Ruxrungtham K
    Southeast Asian J Trop Med Public Health; 2000 Sep; 31(3):482-6. PubMed ID: 11289006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of bacille Calmette-Guérin vaccination at birth on tuberculin skin test reactivity in Ugandan children.
    Mudido PM; Guwatudde D; Nakakeeto MK; Bukenya GB; Nsamba D; Johnson JL; Mugerwa RD; Ellner JJ; Whalen CC
    Int J Tuberc Lung Dis; 1999 Oct; 3(10):891-5. PubMed ID: 10524586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modelling the effect of discontinuing universal Bacillus Calmette-Guérin vaccination in an intermediate tuberculosis burden setting.
    Fu H; Lin HH; Hallett TB; Arinaminpathy N
    Vaccine; 2018 Sep; 36(39):5902-5909. PubMed ID: 30143270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [BCG vaccination in West Germany?].
    Styblo K; Ferlinz C
    Pneumologie; 1994 Feb; 48(2):151-5. PubMed ID: 8183867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology of childhood tuberculosis after ceasing universal Bacillus Calmette-Guérin vaccination.
    Kobayashi S; Yoshiyama T; Uchimura K; Hamaguchi Y; Kato S
    Sci Rep; 2021 Aug; 11(1):15902. PubMed ID: 34354146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Bacillus Calmette-Guérin (BCG) vaccine coverage in newborns and infants at risk before and after a change in BCG policy].
    Parache C; Carcopino X; Gossot S; Retornaz K; Uters M; Mancini J; Garnier JM; Minodier P
    Arch Pediatr; 2010 Apr; 17(4):359-65. PubMed ID: 20219333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bacillus Calmette-Guérin immunization in infants born to HIV-1-seropositive mothers.
    Lallemant-Le Coeur S; Lallemant M; Cheynier D; Nzingoula S; Drucker J; Larouze B
    AIDS; 1991 Feb; 5(2):195-9. PubMed ID: 2031692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of BCG vaccination of the newborn: evaluation by a follow-up study of contacts in Bangui.
    Lanckriet C; Lévy-Bruhl D; Bingono E; Siopathis RM; Guérin N
    Int J Epidemiol; 1995 Oct; 24(5):1042-9. PubMed ID: 8557438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Booster effect of tuberculin testing in healthy 6-year-old school children vaccinated with Bacillus Calmette-Guérin at birth in Santiago, Chile.
    Sepulveda RL; Burr C; Ferrer X; Sorensen RU
    Pediatr Infect Dis J; 1988 Aug; 7(8):578-81. PubMed ID: 3140208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isoniazid resistant tuberculosis in a school outbreak: the protective effect of BCG.
    Shannon A; Kelly P; Lucey M; Cooney M; Corcoran P; Clancy L
    Eur Respir J; 1991 Jul; 4(7):778-82. PubMed ID: 1954998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacillus Calmette-Guérin (BCG) vaccine adverse events in Victoria, Australia: analysis of reports to an enhanced passive surveillance system.
    Clothier HJ; Hosking L; Crawford NW; Russell M; Easton ML; Quinn JA; Buttery JP
    Drug Saf; 2015 Jan; 38(1):79-86. PubMed ID: 25475539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can BCG-vaccinated children be included in tuberculin surveys to estimate the annual risk of tuberculous infection in India?
    Chadha VK; Jagannatha PS; Kumar P
    Int J Tuberc Lung Dis; 2004 Dec; 8(12):1437-42. PubMed ID: 15636489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case for Bacillus Calmette-Guérin vaccine in United States-born children.
    Smith KC; Green HL
    Pediatr Infect Dis J; 1999 Jan; 18(1):15-7. PubMed ID: 9951973
    [No Abstract]   [Full Text] [Related]  

  • 20. [Tuberculosis in Iceland. 1976].
    Sigurdsson S
    Laeknabladid; 2005 Jan; 91(1):69-102. PubMed ID: 16155306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.